Apellis Pharmaceuticals, Inc. (APLS)
41.03
0.00 (0.00%)
USD |
NASDAQ |
May 15, 16:00
Apellis Pharmaceuticals Price : 41.03 for May 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 192.95 |
| Eli Lilly & Co. | 1004.92 |
| Agios Pharmaceuticals, Inc. | 28.17 |
| Spyre Therapeutics, Inc. | 74.92 |
| Scholar Rock Holding Corp. | 49.35 |
Price Related Metrics
| PE Ratio | 41.01 |
| PS Ratio | 4.772 |
| Price to Book Value | 12.66 |
| Price to Free Cash Flow | 140.77 |
| Earnings Yield | 2.44% |
| Market Cap | 5.253B |
| Operating PE Ratio | 31.92 |
| Normalized PE Ratio | 41.01 |